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Abstract 
Background: Acanthamoeba keratitis (AK) is potentially a sight-threatening infection and its treatment is 
challenging. This is mainly due to presence of resistant cyst form. Indeed, cysts are highly resistant to current 
available drugs. Chemical drugs are toxic to human keratocytes. It should also be mentioned that most available 
anti-Acanthamoeba drugs are poorly cysticidal, In Iran and worldwide, AK cases continue to rise and therefore, 
novel effective drugs are urgently needed for the treatment of AK. 
Materials and Methods: In the present study, the in vitro activity of serial dilutions (10, 15, 20 and 25 mg/mL) 
of chloroformic fractions including primary chloroformic fraction (minimum amount of chloroform), middle 
chloroformic fraction and remaining chloroformic fraction (most amount of chloroform) of Trigonella foenum 
graecum seed were evaluated against Acanthamoeba trophozoites and cysts. Cytotoxic assay of fractions at 
different concentrations (25, 50, 100, 200, 300, 400, 500 mg/ml) of test material was identified on mice 
Macrophage cells using MTT method. 
Results: The obtained results revealed that the tested fractions presented anti-amoebic activities in a time and 
dose dependent cycle. Anti-Acanthamoeba activity of remaining chloroformic fraction was more than other 
fractions. Trophozoites/cysts were eliminated when incubated with 15 and 20 mg/ml concentrations of 
remaining chloroformic fraction after 24 hours. Viability of macrophage cells was noted 100 % with 25 and 
50 mg/ml concentration of remaining chloroformic fraction. Our results indicate that the plant fractions are 
safe for mammalian cells. 
Conclusion: Further studies should be performed in order to detect the active chemical compounds which could be 
used for the development of novel therapeutic approaches against Acanthamoeba infections. To the best of our 
knowledge, this is the first study on the activity of chloroformic fractions of Trigonella foenum graecum (seed) 
against Acanthamoeba spp. 
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Acanthamoeba spp. is a genus of free-living 
protozoa. This protozoa is introduced as a widespread 
organism, and can be found on every continent, as 
well as in air-conditioning units, in water mains, 
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showers, sanitary and dental equipment, contact lens 
care solutions, and infected tissue cultures. The life 
cycle of Acanthamoeba consists of a motile 
trophozoite and a double-walled cyst1.  
Invasion in the human can cause fatal encephalitis in 
the immunocompromised patients2 and potentially 
sight-threatening ocular infection termed 
Acanthamoeba keratitis3. Amoebic keratitis is a 
potentially severe ocular infection characterized by 
progressive corneal ulceration. If Acanthamoeba 
keratitis is not diagnosed and treated early, it could 
be lead to perforation, ring infiltration of corneal 
tissue and finally loss of vision1,4. Eradication of 
these amoebas is difficult because, under 
inappropriate conditions, the amoebas are encysted 
and the current therapy is often less effective against 
cyst form than trophozoite form5. Acanthamoeba 
keratitis is usually treated with a combination of 
cationic antiseptics such as polyhexamethylene 
biguanide and aromatic diamidines such as 
propamidine isethionate6,7. Chlorhexidine, alone or in 
combination with propamidine isethionate8,9  is 
another form of treatment options. The current drugs 
against the Acanthamoeba exhibit many toxic effects 
on corneal cells10,11. This leads to severe interest in 
search of safer drug for the treatment. Trigonella 
foenum-graecum L. (Fungreek) is an erect, scented 
annual herb that is extensively cultivated in warm 
temperate and tropical regions in India, the 
Mediterranean region, North Africa, and Iran12. 
Seeds has been documented for its different 
pharmacological activities including 
hypoglycemic13,14 gastro-protective and anti-ulcer 
effects15. The leaves were also evaluated for potent 
antinociceptive, anti-inflammatory and antipyretic 
activities16. Researches revealed that the major 
components of the plant seed are saponins, 
glycoside-D and trigofoenoside-A17, while in the 
leaves are found alkaloids, cardiac glycosides, and 
phenols16.  
The present study was planned to investigate 
amoebicidal activity of the partially separated 
fraction obtained from the Trigonella foenum-
graecum seed extract on the growth of A. castellanii 
trophozoites and cysts and cytotoxic activities of 
fractions on mice Macrophage cell. 
Methods 
Preparation of chloroformic fractions of the plant 
seed  
The dried seeds of the plant were purchased from the 
Ray area of Iran and carefully identified and approved 
by pharmacognosist (Pharmacognosy school, Shahid 
Beheshti University of Medical Science, Tehran, Iran). 
Dried coarsely powdered seeds (500 g) were extracted 
with boiling distilled water using Soxhlet apparatus at 
80±2oC for 10  hours. The solvent was evaporated by 
distillation and under vacuum. To obtain the fractions 
successive liquid-liquid partitioning was used. The 
raw sticky extract was subsequently adjacent to 
chloroform several times. Thus three separate phase 
including primary chloroformic fraction (minimum 
amount of chloroform), middle chloroformic fraction 
and remaining chloroformic fraction (most amount of 
chloroform) were obtained17.  
Acanthamoeba strain  
The Acanthamoeba strain isolated in this study was 
obtained from a patient with AK. Diagnosis of AK 
was based on culture and sequencing based tests. The 
specimen was inoculated onto the surface of 1.5% 
non-nutrient agar (NNA) along with Escherichia coli 
and incubated at 26˚C for 72 hours. PCR was used to 
confirm the microscopic identification. Sequencing 
followed by BLAST search of the isolate revealed the 
presence of T4 genotypes. Cloning of the amoeba was 
done in order to eliminate any bacterial and fungal 
contamination of the plates18,19. The Acanthamoeba 
strain was then kept in NNA culture until further use. 
Trophozoites preparation 
Acanthamoeba Spp.  was grown in axenic medium 
according to our previous study20. Trophozoites in the 
stage of exponential growth (72 to 96 h) were 
identified by inverted microscope. For the experiment, 
one ml of the culture was centrifuged (5 min at 2000g) 
and the sediment washed twice with phosphate-
buffered saline buffer (PBS). The trophozoites 
viability was determined using eosin 0/1% and direct 
trophozoite counts were done using a neubauer cell-
counter chamber. Final concentration was adjusted to 
25 × 104 trophozoites per ml for the activity assays21,22. 
Cysts preparation 
Axenic medium was inoculated directly onto the 
surface of 1.5% non-nutrient agar (NNA) plates and 
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incubated in a humidified chamber at 26˚C. Cysts 
were identified by microscope after several days. The 
agar surface was then flooded with 5 ml of PBS and 
were scraped with a sterile loop. Cysts were 
harvested from the suspension by centrifugation 
(1500 g for 5 min). The sediment was then washed 
twice in PBS. Cysts in the obtained suspension were 
counted with a neubauer cell-counter chamber, and 
the suspension was adjusted to 25×104 cysts per 
milliliter for the cystidical activity assays22,23. 
Evaluation of activity 
Plant chloroformic fractions were prepared according 
to following concentrations: 10, 15, 20 and 25 
mg/mL. To this end, 100-150 µl of the calibrated 
cyst/ trophozoite suspension (25×104/ml) was 
inoculated in each microcentrifuge tubes and 150μl 
of each extract concentration was added into the 
tubes. Incubation was done at 26˚C with different 
incubation periods (24, 48 and 72 h). In addition, 
untreated control (negative control) containing only 
the parasite plus PBS (without extracts) and treated 
control (positive control) containing the parasite plus 
0.02% chlorhexidine gluconate (prepared from a 
solution 20% in water CHX, C-9394; Sigma) were 
used. Three tubes were used for the evaluation of 
each concentration and measurements were repeated 
5 times24. 
Fractions effect against trophozoite and cyst stage 
Twenty five μl from each test and control well was 
added into the same volume of 0.1% eosin. The 
number of amoebae were identified by means of an 
inverted microscope and trophozoites and cysts were 
counted in a counting chamber after each incubation 
period. Viability was assessed using eosin 0/1% and 
approximately 100 Acanthamoeba trophozoites were 
examined in each time. Additionally, the cultures 
containing no viable cysts were transferred onto a 
NNA agar coated with E. coli and incubated at 26˚C 
during another three days to confirm the observed 
results24. 
Cytotoxic assay of fractions on Mice Macrophage 
cells using MTT test 
Mice Macrophage cells were obtained from 
peritoneal cavity of mice for the experiment followed 
by culture in RPMI-1640 medium. The other step 
was the removal of 75μl (15000 cell) from the 
suspension and the cells were transferred to wells of 
96-well plate. The cells were then kept at 37° C in a 
5% CO2 air incubator and passaged every day. Ten μl 
of fractions with different concentrations (25-500 
mg/ml) were added separately to all wells except the 
controls and the plates were mixed well. The cells 
were maintained at 37°C in a 5% CO2 air incubator 
along 24  hours. After incubation period, cells viability 
were determined using MTT assay. Briefly, cells 
grown in a 96-well plate, were incubated with the 
MTT solution approximately 4 hours. Then a 
formazan dye was quantitated using a ELISA reader 
540 nm wavelength after 15 minutes (viability 
(%)=O.D. TESE/O.D. CONTROL X 100)25. 
Statistical analysis  
The statistical analyses of data were performed using 
SPSS software version 15.0. P values<0.001 were 
considered as statistically highly significant. The IC50 
analysis was done using GraphPad Prism 6. 
Results 
The present study was detected the amoebicidal 
activity of the chloroformic fractions of the seeds of 
Trigonella foenum graecum. Interestingly, remaining 
chloroformic fraction had a high amoebicidal activity 
(MIC=15, 20 mg/ml) against trophozoites and cysts, 
however primary chloroformic fraction and middle 
 
 




Figure 2. Cysts after treatment of chloroformic fractions (x400) 
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chloroformic fraction had less activity against amoebae than remaining chloroformic fraction (Table 
Table 1: Effect of Trigonella foenum graecum chloroformic fractions on the survival and growth of Acanthamoeba 
trophozoite and cysts. 
 
 
MTH1: primary chloroformic fraction 
MTH2: middle chloroformic fraction 
MTH3: remaining chloroformic fraction 
Table 2: Effect of chloroformic fractions of Trigonella foenum graecum on % viability of mice Macrophages after 24h. 
 
Concentrations (mg/ml) %Viability of cells after 
effect of MTH1 
%Viability of cells after 
effect of MTH2 
%Viability of cells after 
effect of MTH3 
25 73.7% 84.8% 100% 
50 65.9% 76.2% 100% 
100 57.7% 74.0% 90.0% 
200 52.6% 64.1% 88.6% 
300 50.6% 56.8% 75.0% 
400 49.9% 54.8% 71.6% 
500 26.2% 32.9% 56.5% 
MTH1: primary chloroformic fraction 
MTH2: middle chloroformic fraction 
MTH3: remaining chloroformic fraction 
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1). On the other hand, at 20 mg/ml concentration of 
primary chloroformic fraction 3.2×104 and 5.53×104 
trophozoites and cysts were lived after 24 hours. In 
same concentration of middle chloroformic fraction 
1.8×104 and 3.2×104 trophozoites and cysts were 
lived. Light microscopy revealed that the untreated 
Acanthamoeba cyst contained double walls: the 
intact ectocyst and endocyst walls. The endocyst 
appeared smooth and a clear space separated it from 
wrinkled ectocyst and non-treated trophozoite 
showed acanthopodia. Cysts treated with the extract 
showed a cytoplasmic clump and rounded walls and 
even some cysts presented empty walls (Figures 1, 
2). Nevertheless, it is important to mention that a 
time and dose dependent amoebicidal action of the 
extract was shown on both stages of the amoebae. 
The 24-hour cytotoxic effects of chloroformic 
fractions of Trigonella foenum graceum (TFG) was 
surveyed on macrophage cells using the MTT test. A 
dose dependent MTT reduction was observed in TFG 
exposed cells. Fractions were added in different 
concentration from 25 to 500mg/ml to the 
macrophage cells and incubated for 24 hours. 
Viability was noted 100% for the 25 and 50 mg/ml 
concentration of remaining chloroformic fraction 
(IC50= 639.6mg/ml) although it estimated 73.7% 
(IC50=215.4mg/ml) and 84.8% (IC50=348.6mg/ml) in 
25mg/ml concentration of primary chloroformic 
fraction and middle chloroformic fraction 
respectively (Table 2). 
Discussion 
Acanthamoeba keratitis is a severe corneal disease 
related to the users of soft contact lenses. This sight 
threatening corneal disease is often treated with 
combination drugs such as polyhexamethylene 
biguanide (PHMB) or chlorhexidine and 
propamidine isethionate. Despite combination 
therapy, only half of the patients have been reported 
to improve after treatment with the therapeutic 
regimens when the disease is not early diagnosed26. 
According to previous researches, biguanides could 
lead to toxic effects on human keratocytes even at the 
lowest cysticidal concentrations27. Long duration of 
treatment course for the mentioned drugs is notable 
and it may even take up to six months28. Poor 
cysticidal effect is the main drawback to the 
mentioned drugs 29,30. Thus, cysts resistance to current 
available drugs have prompted the researchers to 
develop novel anti-amoebic compounds. To date, there 
is a raising pattern to shift resources from currently 
chemical drugs to herbal medicine. Indeed, finding a 
natural compound with amoebicidal and cysticidal 
effect and non-toxic to human cells is of utmost 
priority  to overcome AK cases.  
In our study, the activity of the chloroformic fractions 
of Trigonella foenum graecum seed was evaluated 
against a pathogenic Acanthamoeba strain  since a 
previous study reported that this medicinal plant 
presented anti-parasitic properties when assayed in 
various parasites32,33. The present study showed that 
the tested chloroformic fractions were able to 
eliminate trophozoites and cysts of Acanthamoeba. 
However, we tested a higher concentrations (500 
mg/ml) in comparison with other medicinal plants and 
thus cytotoxic evaluation on macrophage cells was 
carried out. The results confirmed remaining 
chloroformic fraction has no cytotoxic effect on the 
macrophage cells with the dose of 50 mg/ml. 
In addition, T. foenum graecum is a widely used 
medicinal plant in various disorders. Indeed, according 
to previous researches antidiabetic, anti-inflammatory, 
antipyretic34, anthelmintic and antibacterial properties 
were elucidated35. Interestingly, previous studies 
revealed that oral administration of Trigonella foenum 
graecum can cause a significant protection against eye 
cataract in animal model36. 
Conclusion 
Overall, the present research demonstrated that 
remaining chloroformic fraction of T. foenum graecum 
could be used in the near future in order to obtain 
amoebicidal and cysticidal compounds for the 
treatment of Acanthamoeba infections. This is 
mentionable that these fractions have maximum effect 
on Acanthamoeba during 24 hours, thus there is no 
need for more exposure time. Toxicity tests reflected 
that the mentioned fraction have none side-effects. 
Further in vitro and in vivo studies are necessary to 
perform in order to introduce the chemical molecular 
component of remaining chloroformic fraction 
involved in the anti-Acanthamoeba activities. 
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